We are live on ! Find out more
UBS Group

UBS Group Portfolio holdings

AUM $666B
1-Year Est. Return 30.12%
 

UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.

This Fund
S&P 500
This Quarter Est. Return
-3.64%
1 Year Est. Return
+30.12%
3 Year Est. Return
+86.21%
5 Year Est. Return
+101.56%
10 Year Est. Return
+336.66%
AUM
$300B
AUM Growth
-$49.2B
Cap. Flow
-$29.5B
Cap. Flow %
-9.85%
Top 10 Hldgs %
13.34%
Holding
11,668
New
1,182
Increased
3,623
Reduced
5,175
Closed
1,160

Sector Composition

Rank Sector Weight
1 Technology 13.08%
2 Financials 7.19%
3 Healthcare 6.35%
4 Consumer Discretionary 5.55%
5 Industrials 4.21%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TNYA icon
9251
Tenaya Therapeutics
TNYA
$161M
$4K ﹤0.01%
367
-2,923
-89% -$35.4K
TRVI icon
9252
Trevi Therapeutics
TRVI
$2.59B
$4K ﹤0.01%
+1,624
New +$1.68K
UKOMW
9253
DELISTED
Ucommune International Ltd Warrant
UKOMW
$4K ﹤0.01%
43,663
+3,500
+9% +$290
USCB icon
9254
USCB Financial Holdings
USCB
$406M
$4K ﹤0.01%
267
-268
-50% -$3.78K
VRDN icon
9255
Viridian Therapeutics
VRDN
$2.09B
$4K ﹤0.01%
222
+209
+1,608% +$4.02K
VRMEW
9256
DELISTED
VerifyMe, Inc. Warrant
VRMEW
$4K ﹤0.01%
3,875
+2,800
+260% +$2.5K
WBIG icon
9257
WBI BullBear Yield 3000 ETF
WBIG
$30.1M
$4K ﹤0.01%
139
+64
+85% +$1.75K
WINT
9258
DELISTED
Windtree Therapeutics
WINT
0
XELB icon
9259
Xcel Brands
XELB
$7.27M
$4K ﹤0.01%
+259
New +$3.22K
YHGJ icon
9260
Yunhong Green CTI Ltd
YHGJ
$7.54M
$4K ﹤0.01%
+288
New +$2.97K
ZHDG icon
9261
Zega Buy & Hedge ETF
ZHDG
$35.2M
$4K ﹤0.01%
+223
New +$4.41K
BLNE
9262
Beeline Holdings
BLNE
$28.8M
$4K ﹤0.01%
+23
New +$5.23K
PAVMZ
9263
DELISTED
PAVmed Inc. Series Z Warrant
PAVMZ
$4K ﹤0.01%
4,943
+3,808
+336% +$3.92K
WMPN
9264
DELISTED
William Penn Bancorporation Common Stock
WMPN
$4K ﹤0.01%
347
-672
-66% -$8.45K
CTV.WS
9265
DELISTED
Innovid Corp. Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 per share
CTV.WS
$4K ﹤0.01%
4,556
+1,088
+31% +$967
TETEU
9266
DELISTED
Technology & Telecommunication Acquisition Corporation Unit
TETEU
$4K ﹤0.01%
+355
New +$3.57K
PRLH
9267
DELISTED
Pearl Holdings Acquisition Corp Class A Ordinary Shares
PRLH
$4K ﹤0.01%
+420
New +$4.14K
BFAC
9268
DELISTED
Battery Future Acquisition Corp.
BFAC
$4K ﹤0.01%
+395
New +$3.9K
MCAGU
9269
DELISTED
Mountain Crest Acquisition Corp. V Unit
MCAGU
$4K ﹤0.01%
366
-1,000
-73% -$10K
MCAA
9270
DELISTED
Mountain & Co. I Acquisition Corp. Class A Ordinary Shares
MCAA
$4K ﹤0.01%
+360
New +$3.61K
JWSM.WS
9271
DELISTED
Jaws Mustang Acquisition Corp. Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
JWSM.WS
$4K ﹤0.01%
8,473
+5,275
+165% +$3.41K
ZPTA
9272
DELISTED
Zapata Computing Holdings Inc. Common Stock
ZPTA
$4K ﹤0.01%
+390
New +$3.88K
RNLX
9273
DELISTED
Renalytix plc American Depositary Shares
RNLX
$4K ﹤0.01%
600
-2,543
-81% -$26.9K
TLIS
9274
DELISTED
Talis Biomedical Corporation Common Stock
TLIS
$4K ﹤0.01%
183
-316
-63% -$10.9K
IMAQU
9275
DELISTED
International Media Acquisition Corp. Unit
IMAQU
$4K ﹤0.01%
406
-500
-55% -$5.1K

Similar funds

UBS Group's Q1 2022 Portfolio in Review

As of Q1 2022, UBS Group held 11,668 positions worth $300B, down 14% from $349B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

UBS Group withdrew a net $29.5B in Q1 2022, closing 1,160 positions and reducing 5,175 holdings. Its most notable exit was Xilinx Inc, an estimated $186M position sold in full.

By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 12% a quarter earlier, followed by Financials and Healthcare.

Against the trend, UBS Group opened a new position in Shell worth $66.6M.

  • UBS Group's largest Q1 2022 buy was Shell: 1,213,213 shares worth $66.6M.
  • UBS Group added most to Tesla in Q1 2022, an estimated $388M increase.
  • UBS Group's biggest Q1 2022 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $911M.
  • UBS Group fully exited Xilinx Inc in Q1 2022, selling an estimated $186M.
  • UBS Group's ten largest holdings make up 13% of its $300B portfolio in Q1 2022.
  • UBS Group opened 1,182 new positions and closed 1,160 in Q1 2022.
  • UBS Group's portfolio value fell 14% quarter-over-quarter to $300B.

Based on UBS Group's 13F filing for Q1 2022, filed 16 May 2022.